ANVS Falls Nearly 48% as $21 Million Offering Puts Dilution in Focus
Annovis Bio's share-and-warrant offering raises funding while adding ownership pressure, against the backdrop of a recent NYSE compliance notice.
Read the story
Annovis Bio's share-and-warrant offering raises funding while adding ownership pressure, against the backdrop of a recent NYSE compliance notice.
Read the story
SANUWAVE faces a roughly 21% physician-office reimbursement reduction for 2027, while higher hospital payments offer a partial counterweight.

Elong Power's $3.26 million warrant agreement offers fresh funding while adding shares and potential future dilution after a volatile trading reversal.

ThredUp's holiday-quarter revenue forecast missed expectations, putting profitability and analyst downgrades in focus after a sharp selloff.

Teads' weak quarter combines falling revenue, negative adjusted EBITDA and substantial debt; its large noncash impairment must be separated from cash burn.

A revenue miss, weaker outlook and sales-team disruption explain why MNTN's growing earnings failed to reassure investors.

Fluent's growing commerce-media business explains why its next earnings release deserves attention, but losses and financing risk remain central.

A long-term Marc Jacobs license strengthens Coty's brand story while first-quarter results show why investors should distinguish core-brand growth from division-wide performance.

Record quarterly revenue and stronger margins give Arq a tangible earnings story, while restricted cash remains an important qualification.

NetClass stands out on the gainers screen, but its AI teaching award and recent share issuance tell different parts of the investment story.
Krispy Kreme lifted its full-year revenue forecast, but declining quarterly revenue and a net loss show the turnaround remains unfinished.

Aemetis reported third-quarter revenue of $88.2 million and net income of $5.2 million. Clean-fuel tax credits and a first-half adjustment complicate the run-rate picture.